drugset / Trial / NCT06901323

Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria

NCT06901323

Phase 4 Active not recruiting 176 enrolled Mansoura University
RandomizedSequentialOpen-labelSupportive care

Summary

Effect of L-carnitine supplementation on phenylalanine and brain-derived neurotrophic factor levels in infants and children with phenylketonuria L-carnitine is mainly obtained from foods such as red meat and milk that are limited for PKU patients due to dietary protein restriction. So, L-carnitine deficiency has been described in phenylketonuric patients The aim of this study is to : 1. Compare level of Brain-derived neurotrophic factor in infants and children with phenylketonuria and healthy infants and children. 2. Compare level of phenylalanine and Brain-derived neurotrophic factor before and after L-carnitine supplementation in phenylketonuric patients. 3. Assess Intelligence quotient test before and after L-carnitine supplementation in phenylketonuric patients

Timeline

Start
2025-02-01
Primary completion
2026-03-01
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 100 mg/kg

Indications